126 related articles for article (PubMed ID: 10101099)
1. Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes.
Petrikovics I; Hong K; Omburo G; Hu QZ; Pei L; McGuinn WD; Sylvester D; Tamulinas C; Papahadjopoulos D; Jaszberenyi JC; Way JL
Toxicol Appl Pharmacol; 1999 Apr; 156(1):56-63. PubMed ID: 10101099
[TBL] [Abstract][Full Text] [Related]
2. Comparing therapeutic and prophylactic protection against the lethal effect of paraoxon.
Petrikovics I; Papahadjopoulos D; Hong K; Cheng TC; Baskin SI; Jiang J; Jaszberenyi JC; Logue BA; Szilasi M; McGuinn WD; Way JL
Toxicol Sci; 2004 Feb; 77(2):258-62. PubMed ID: 12857941
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation of phosphotriesterase within murine erythrocytes.
Pei L; Omburo G; McGuinn WD; Petrikovics I; Dave K; Raushel FM; Wild JR; DeLoach JR; Way JL
Toxicol Appl Pharmacol; 1994 Feb; 124(2):296-301. PubMed ID: 8122276
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of the lethal effects of paraoxon by carrier erythrocytes containing phosphotriesterase.
Pei L; Petrikovics I; Way JL
Fundam Appl Toxicol; 1995 Dec; 28(2):209-14. PubMed ID: 8835230
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism.
Petrikovics I; McGuinn WD; Sylvester D; Yuzapavik P; Jiang J; Way JL; Papahadjopoulos D; Hong K; Yin R; Cheng TC; DeFrank JJ
Drug Deliv; 2000; 7(2):83-9. PubMed ID: 10892408
[TBL] [Abstract][Full Text] [Related]
6. Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism.
Petrikovics I; Cheng TC; Papahadjopoulos D; Hong K; Yin R; DeFrank JJ; Jaing J; Song ZH; McGuinn WD; Sylvester D; Pei L; Madec J; Tamulinas C; Jaszberenyi JC; Barcza T; Way JL
Toxicol Sci; 2000 Sep; 57(1):16-21. PubMed ID: 10966507
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical characterization of stealth liposomes encapsulating an organophosphate hydrolyzing enzyme.
Budai M; Chapela P; Gróf P; Zimmer A; Wales ME; Wild JR; Klebovich I; Petrikovics I; Szilasi M
J Liposome Res; 2009; 19(2):163-8. PubMed ID: 19235545
[TBL] [Abstract][Full Text] [Related]
8. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicol Appl Pharmacol; 1996 Dec; 141(2):555-60. PubMed ID: 8975781
[TBL] [Abstract][Full Text] [Related]
9. Stereochemical constraints on the substrate specificity of phosphotriesterase.
Hong SB; Raushel FM
Biochemistry; 1999 Jan; 38(4):1159-65. PubMed ID: 9930975
[TBL] [Abstract][Full Text] [Related]
10. Modulation of innate immunological factors by STEALTH liposome-encapsulated tumor necrosis factor-alpha in a colon tumor xenograft model.
Kim DW; Andres ML; Kajioka EH; Dutta-Roy R; Miller GM; Seynhaeve AL; ten Hagen TL; Gridley DS
Anticancer Res; 2002; 22(2A):777-88. PubMed ID: 12014650
[TBL] [Abstract][Full Text] [Related]
11. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase.
Lockridge O; Blong RM; Masson P; Froment MT; Millard CB; Broomfield CA
Biochemistry; 1997 Jan; 36(4):786-95. PubMed ID: 9020776
[TBL] [Abstract][Full Text] [Related]
12. Eptastigmine-phosphotriesterase combination in DFP intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
[TBL] [Abstract][Full Text] [Related]
13. Acute renal failure enhances the antidotal activity of pralidoxime towards paraoxon-induced respiratory toxicity.
Kayouka M; Houzé P; Debray M; Baud FJ
Toxicol Lett; 2009 Aug; 189(1):48-56. PubMed ID: 19406220
[TBL] [Abstract][Full Text] [Related]
14. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
15. Spectrophotometric determination of paraoxonase within mouse carrier red blood cells.
Pei L; McGuinn WD; Omburo G; Zitzer AH; Petrikovics I; Way JL
Biotechnol Appl Biochem; 1994 Aug; 20(1):35-41. PubMed ID: 7917064
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and toxicodynamics of pralidoxime effects on paraoxon-induced respiratory toxicity.
Houzé P; Mager DE; Risède P; Baud FJ
Toxicol Sci; 2010 Aug; 116(2):660-72. PubMed ID: 20498006
[TBL] [Abstract][Full Text] [Related]
17. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicology; 1999 Jun; 134(2-3):169-78. PubMed ID: 10403635
[TBL] [Abstract][Full Text] [Related]
18. Effect of intrathecal pralidoxime administration upon survival of rats exposed to the organophosphate paraoxon.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Nagelkerke N; Petroianu GA
Neurotoxicology; 2008 Jul; 29(4):663-70. PubMed ID: 18457881
[TBL] [Abstract][Full Text] [Related]
19. Characterization of P-S bond hydrolysis in organophosphorothioate pesticides by organophosphorus hydrolase.
Lai K; Stolowich NJ; Wild JR
Arch Biochem Biophys; 1995 Apr; 318(1):59-64. PubMed ID: 7726573
[TBL] [Abstract][Full Text] [Related]
20. Oral treatment of organophosphate poisoning in mice.
Bowls BJ; Freeman JM; Luna JA; Meggs WJ
Acad Emerg Med; 2003 Mar; 10(3):286-8. PubMed ID: 12615598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
